VANCOUVER, Wash. and NEW YORK — October 29, 2025 — Leads & Copy — Absci (Nasdaq: ABSI) will report its third quarter 2025 business updates, along with financial and operating results, after market close on Wednesday, November 12, 2025. The company’s management is set to host a conference call at 4:30 p.m. ET to discuss these developments.
The webcast will be archived and available for replay after the event. Live audio will be available on the investor relations website.
Absci is using generative design to create better biologics for patients, faster. The Integrated Drug Creation™ platform combines AI models with a synthetic biology data engine, enabling the rapid design of innovative therapeutics that address challenging therapeutic targets. Absci is headquartered in Vancouver, WA, with an AI Research Lab in New York City, and Innovation Center in Switzerland.
Investor Contact: Alex Khan, VP, Finance & Investor Relations, investors@absci.com
Media Contact: press@absci.com
Source: Absci
